Pharmacom Competitors
| PHMB Stock | USD 0.0001 0.00 0.00% |
Pharmacom Biovet vs Herborium Correlation
Pharmacom Biovet Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Pharmacom Biovet and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Pharmacom and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Pharmacom Biovet does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pharmacom Stock performing well and Pharmacom Biovet Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharmacom Biovet's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MAHN | 27.13 | 11.97 | 0.00 | 1.48 | 0.00 | 0.00 | 970.91 | |||
| AMBD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ARPC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CYDX | 14.82 | 6.19 | 0.00 | 1.92 | 0.00 | 15.91 | 440.74 | |||
| DTRK | 5.86 | 0.32 | 0.02 | 0.28 | 8.37 | 16.47 | 74.42 | |||
| ESMC | 1.39 | 0.05 | 0.00 | (2.72) | 2.38 | 6.67 | 19.22 | |||
| LGND | 1.68 | 0.07 | 0.01 | 0.44 | 2.03 | 3.51 | 18.09 | |||
| BINP | 11.96 | 2.98 | 0.09 | (0.67) | 13.88 | 34.69 | 176.17 | |||
| MRZM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HBRM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cross Equities Net Income Analysis
Compare Pharmacom Biovet and related stocks such as Mid Atlantic Home, American Mobile Dental, and Arem Pacific Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMBD | 1.3 K | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (150.5 K) | (135.4 K) | (128.7 K) |
| LGND | (27.1 M) | 10.2 M | (527 K) | 11.4 M | 12 M | 257.3 M | (1.6 M) | 12.6 M | 143.3 M | 629.3 M | (3 M) | 57.1 M | (33.4 M) | 52.2 M | (4 M) | (4.6 M) | (4.4 M) |
Pharmacom Biovet and related stocks such as Mid Atlantic Home, American Mobile Dental, and Arem Pacific Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Pharmacom Biovet financial statement analysis. It represents the amount of money remaining after all of Pharmacom Biovet operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Pharmacom Biovet Competitive Analysis
The better you understand Pharmacom Biovet competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Pharmacom Biovet's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Pharmacom Biovet's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Pharmacom Biovet Competition Performance Charts
Five steps to successful analysis of Pharmacom Biovet Competition
Pharmacom Biovet's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Pharmacom Biovet in relation to its competition. Pharmacom Biovet's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Pharmacom Biovet in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Pharmacom Biovet's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Pharmacom Biovet, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Pharmacom Biovet position
In addition to having Pharmacom Biovet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Pharmacom Biovet Correlation with its peers. For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmacom Biovet. Anticipated expansion of Pharmacom directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pharmacom Biovet assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Pharmacom Biovet's market price often diverges from its book value, the accounting figure shown on Pharmacom's balance sheet. Smart investors calculate Pharmacom Biovet's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Pharmacom Biovet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Pharmacom Biovet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pharmacom Biovet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Pharmacom Biovet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.